![]() |
Volumn 6, Issue 4, 1999, Pages 797-800
|
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
PACLITAXEL;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG RESISTANCE;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PACLITAXEL;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0033159088
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.6.4.797 Document Type: Article |
Times cited : (31)
|
References (0)
|